Competition

Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.



Sign up for a 7-day FREE trial today!



Latest News in Competition

  • June 24, 2026

    Tracking The Rare 'Quick Look' Win In FTC's Zillow-Redfin Suit

    The Federal Trade Commission’s suit claiming that Zillow illegally paid Redfin to exit the apartment rental market is one to watch because its early success under the less rigorous “quick look” standard of antitrust review could turn into a rare case won under the doctrine, say attorneys at Axinn.

  • June 24, 2026

    Claritev Can't Use 'Unclean Hands' Defense In Antitrust MDL

    Healthcare data firm Claritev and a group of major insurers can't assert an unclean hands defense in multidistrict litigation accusing payors of scheming to fix reimbursement rates through the data firm's pricing tools, an Illinois federal judge ruled Wednesday.

  • June 24, 2026

    Fla. Judge Pauses Antitrust Suit Against Brokerages

    A Florida federal judge has paused a proposed broker fees antitrust class action that was filed against Douglas Elliman Inc. and HomeServices of America Inc. due to the pending final settlement approval for a separate but similar case.

  • June 23, 2026

    FAR Council Takes Aim At Acquisitions, Contract Terminations

    The Trump administration kicked off the formal rulemaking process as part of its effort to streamline the Federal Acquisition Regulation, releasing four proposed rules covering everything from competition requirements and acquisition planning to contract terminations and protests. 

  • June 23, 2026

    FTC Tells 4th Circ. Court Got It Wrong In J&J Stelara Case

    The Federal Trade Commission has told the Fourth Circuit that a Virginia federal court messed up when it ruled in an antitrust suit against Johnson & Johnson that the company bringing the suit needed to show specific intent in order to prop up a monopolization claim over the immunosuppressive drug Stelara.

See more Competition news

Competition

Areas of Coverage

  • AGENCIES
  • U.S. Department of Justice, Antitrust Division
  • Federal Trade Commission, Bureau of Competition
  • European Commission, Competition Directorate
  • UK Competition and Markets Authority
  • Germany’s Federal Cartel Office
  • China’s Ministry Of Commerce
  • Japan Fair Trade Commission
  • Korea Fair Trade Commission
  • Canada’s Competition Bureau
  • Brazil’s Council for Economic Defense
  • POLICY & REGULATION
  • Clayton Act
  • Federal Trade Commission Act
  • Foreign Corrupt Practices Act
  • Racketeer Influenced and Corrupt Organizations Act
  • Robinson-Patman Act
  • Sherman Act
  • International antitrust legislation and regulation
  • ENFORCEMENT
  • Criminal charges over antitrust issues
  • Global cartel investigations and actions
  • Merger reviews and second requests
  • Merger challenges and divestiture orders
  • Anti-monopoly actions
  • Pharmaceutical pay-for-delay challenges
  • Bid-rigging probes
  • Kickback, bribery, and corruption cases
  • Challenges to state aid and other subsidies
  • LITIGATION
  • Antitrust class actions
  • Price-fixing cases
  • Illegal monopoly suits
  • PROFILES
  • Personnel moves
  • Profiles of competition practices

Readership

  • Antitrust and competition lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals